logo

Aeterna Zentaris Inc (AEZS)



Trade AEZS now with
  Date
  Headline
12/7/2020 8:11:36 AM Aeterna Zentaris Enters Exclusive Licensing Agreement With Consilient Health, Ltd.
11/16/2020 8:15:40 AM Aeterna Zentaris Amends License Agreement With Novo Nordisk
11/6/2020 8:40:12 AM Aeterna Zentaris Q3 Consolidated Net Loss $1.1 Mln Or $0.02 Per Basic Share
9/16/2020 8:19:17 AM Aeterna Zentaris Expects Pivotal Phase 3 Safety, Efficacy Study AEZS-130-P02 To Begin In Q1'21
6/25/2020 8:17:35 AM Aeterna Zentaris Enters Exclusive Distribution And Related Quality Agreement With Megapharm
6/8/2020 8:12:53 AM Aeterna Zentaris Regains Compliance With Minimum Bid Price For Continued Listing On Nasdaq Capital Market
4/6/2020 9:12:25 AM Aeterna Zentaris Announces Positive Results For First Pediatric Study Of Macimorelin
1/27/2020 8:39:05 AM Aeterna Zentaris Regains Compliance With Nasdaq Minimum Bid Price Requirement For Continued Listing
8/20/2019 11:19:13 PM Aeterna Zentaris Director Jonathan Pollack Resigns
1/16/2019 9:07:46 AM Aeterna Zentaris Says European Medicines Agency Grants Marketing Authorization For Macimorelin
11/19/2018 8:09:48 AM Aeterna Zentaris Gets Positive CHMP Opinion Of Macimorelin For Diagnosis Of Adult Growth Hormone Deficiency
9/25/2018 8:03:25 AM Aeterna Zentaris Appoints Leslie Auld As CFO